Provider preferences for anal cancer prevention screening - PMC
For years, screening practices for anal cancer were highly variable due to a lack of national standards. This changed significantly in 2024 following the results of the , a large randomized clinical trial which proved that treating high-grade anal lesions significantly reduces the incidence of anal cancer by approximately 57%. Key Screening Tools analscreen judith
Strategies for screening and early detection of anal cancers - PubMed Provider preferences for anal cancer prevention screening -
Abstract * Objective. This study explores provider preferences regarding anal cancer screening indications, initiation age, tools, National Institutes of Health (.gov) analscreen judith
In the broader context of , the field has recently entered a new era of formalized guidelines and improved detection methods designed to reduce the rising incidence of anal squamous cell carcinoma (SCC). The Evolution of Anal Cancer Screening